Literature DB >> 30964577

Human cytomegalovirus IL-10 augments NK cell cytotoxicity.

Kayla A Holder1, Michael D Grant1.   

Abstract

Human cytomegalovirus (HCMV) persistently infects most of the adult population with periods of productive and latent infection differentially orchestrated by multiple HCMV-encoded gene products. One HCMV gene (UL111a) encodes cmvIL-10, a virokine homologous to human IL (hIL)-10. Although the effects of cmvIL-10 on most human lymphocyte subsets have been extensively studied, its impact on NK cell function was unreported prior to this study. We investigated effects of short-term cmvIL-10 exposure on human NK cells and found it substantially enhanced NK cell cytotoxicity through natural cytotoxicity receptors NKp30 and NKp46 as well as through C-type lectin-like receptors NKG2C and NKG2D. Antibody-dependent cell-mediated cytotoxicity triggered through CD16 also increased significantly with short-term cmvIL-10 exposure. These effects of cmvIL-10 on NK cell cytotoxicity were rapid, dose dependent, neutralized by polyclonal anti-cmvIL-10 or monoclonal anti-IL-10 receptor (IL-10R) antibodies and independent of increased perforin synthesis or up-regulation of activating receptors. A low percentage (0.5-5.4%; n = 12) of NK cells expressed IL-10R and the impact of cmvIL-10 on NK cells degranulation following CD16 stimulation directly correlated with this percentage (P = 0.0218). Short-term exposure of human NK cells to cmvIL-10 did not introduce phenotypic changes reminiscent of NK adaptation to HCMV infection in vivo. Determining how expression of a viral protein that activates NK cells contributes to their function in vivo will increase understanding of HCMV infection and NK cell biology. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  ADCC; HCMV; NK cell; cmvIL-10; cytotoxicity; hIL-10R

Year:  2019        PMID: 30964577     DOI: 10.1002/JLB.2AB0418-158RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis.

Authors:  Xin Liu; Kangming Lin; Xielin Huang; Wangkai Xie; Dan Xiang; Ning Ding; Changyuan Hu; Xian Shen; Xiangyang Xue; Yingpeng Huang
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-05       Impact factor: 4.553

2.  Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.

Authors:  Sergi Pascual-Guardia; Michelle Ataya; Isabel Ramírez-Martínez; José Yélamos; Roberto Chalela; Salomé Bellido; Miguel López-Botet; Joaquim Gea
Journal:  Respir Res       Date:  2020-03-04

3.  Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis.

Authors:  Jiahui Wang; Yelei Han; Jing Feng
Journal:  BMC Pulm Med       Date:  2019-12-19       Impact factor: 3.317

Review 4.  The Effect of Unconventional Cytokine Combinations on NK-Cell Responses to Viral Infection.

Authors:  David E Ochayon; Stephen N Waggoner
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 8.786

5.  IL-10 Enhances Human Natural Killer Cell Effector Functions via Metabolic Reprogramming Regulated by mTORC1 Signaling.

Authors:  Zixi Wang; Di Guan; Jianxin Huo; Subhra K Biswas; Yuhan Huang; Yuansheng Yang; Shengli Xu; Kong-Peng Lam
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

6.  β-Glucan-Induced IL-10 Secretion by Monocytes Triggers Porcine NK Cell Cytotoxicity.

Authors:  Leen Hermans; Steffi De Pelsmaeker; Sofie Denaeghel; Eric Cox; Herman W Favoreel; Bert Devriendt
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

Review 7.  microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells.

Authors:  Mengyao Yu; Yuexinzi Jin; Shichang Zhang; Jian Xu; Jiexin Zhang
Journal:  Vaccines (Basel)       Date:  2022-01-19

Review 8.  Reprogramming the tumor microenvironment by genome editing for precision cancer therapy.

Authors:  Ke Liu; Jia-Jia Cui; Yan Zhan; Qian-Ying Ouyang; Qi-Si Lu; Dong-Hua Yang; Xiang-Ping Li; Ji-Ye Yin
Journal:  Mol Cancer       Date:  2022-04-11       Impact factor: 27.401

9.  Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.

Authors:  Na Li; Lingfeng Zhao; Xianquan Zhan
Journal:  J Cell Physiol       Date:  2020-09-22       Impact factor: 6.513

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.